Download PDF
Tierarztl Prax Ausg K Kleintiere Heimtiere 2020; 48(01): 26-37
DOI: 10.1055/a-1020-3341
Übersichtsartikel

Therapie der kaninen Parvovirose – Übersicht und aktuelle Erkenntnisse

Therapy of canine parvovirus infection – review and current insights
Moira Gerlach
1   Akademie für Tierschutz, Neubiberg
,
Anna-Lena Proksch
2   Klinik für Kleintiere, Justus-Liebig-Universität Gießen
,
René Dörfelt
3   Medizinische Kleintierklinik, Ludwig-Maximilians-Universität München
,
Stefan Unterer
3   Medizinische Kleintierklinik, Ludwig-Maximilians-Universität München
,
Katrin Hartmann
3   Medizinische Kleintierklinik, Ludwig-Maximilians-Universität München
› Author Affiliations
› Further Information
    Permissions and Reprints

Zusammenfassung

Die kanine Parvovirose ist nach wie vor eine weltweit verbreitete und vor allem bei Welpen häufig auftretende Infektionskrankheit. Die Therapie erfolgt überwiegend symptomatisch und beinhaltet die Behandlung der akuten gastrointestinalen Symptome sowie die Behandlung und Prävention einer möglichen Sepsis aufgrund bakterieller Translokation. Neben der antibiotischen Behandlung und der essenziellen Flüssigkeitstherapie ist eine ausreichende antiemetische und analgetische Medikation sinnvoll. Weiterhin sollte eine möglichst frühzeitige enterale Ernährung angestrebt werden, da dies die Genesungszeit verkürzt. Die gezielte Modulation der intestinalen Mikrobiota kann die klinische Symptomatik reduzieren und möglicherweise langfristige Folgen, wie chronische Darmerkrankungen, verhindern. Eine antivirale Therapie mit dem rekombinanten felinen Interferon-Omega führte in mehreren Studien zu einer geringeren Mortalitätsrate und einer schnelleren Besserung der klinischen Symptome.

Abstract

Canine parvovirus infection remains to represent a worldwide and commonly occurring infectious disease leading to severe morbidity especially in puppies. The main therapeutic approach is primarily based on symptomatic treatment, especially addressing acute gastrointestinal signs as well as treating and preventing potential sepsis due to bacterial translocation. Besides antibiotic and essential fluid therapy, the use of efficient antiemetic and pain medication is required. In addition, early enteral nutrition should be attempted as this has been shown to be associated with a shorter time to recovery. Modulation of the intestinal microbiome could improve clinical signs and possibly aide in avoiding long-term sequelae such as chronic gastrointestinal disease. Treatment with recombinant feline interferon-omega resulted in a lower mortality and a more rapid improvement of clinical signs in several experimental and clinical studies and thus is considered to be effective.

Schlüsselwörter

CPV - kanines Parvovirus - Behandlung - Hund - antiviral - Interferon - intestinales Mikrobiom

Key words

CPV - canine parvovirus - treatment - dog - antiviral - interferon - intestinal microbiome


Publication History

Received: 22 January 2019

Accepted: 20 August 2019

Article published online:
14 February 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Alvillar BM, Boscan P, Mama KR. et al. Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane minimum alveolar concentration (MAC) in dogs. Vet Anaesth Analg 2012; 39: 201-205
    CrossrefPubMedGoogle Scholar
  • 2 Appel MJ, Scott FW, Carmichael LE. Isolation and immunisation studies of a canine parvo-like virus from dogs with haemorrhagic enteritis. Vet Rec 1979; 105: 156-159
    CrossrefPubMedGoogle Scholar
  • 3 Arslan HH, Saripinar Aksu D, Terzi G. et al. Therapeutic effects of probiotic bacteria in parvoviral enteritis in dogs. Revue Méd Vét 2012; 163: 55-59
    PubMedGoogle Scholar
  • 4 Balakrishnan A, Silverstein D. Shock fluids and fluid changes. In: Silverstein D, Hopper K. eds. Small Animal Critical Care Medicine. Philadelpia: Elsevier Saunders; 2014: 321-327
    Google Scholar
  • 5 Batz MB, Henke E, Kowalcyk B. Long-term consequences of foodborne infections. Infect Dis Clin North Am 2013; 27: 599-616
    CrossrefPubMedGoogle Scholar
  • 6 Beal MW, Hughes D. Vascular access: theory and techniques in the small animal emergency patient. Clin Tech Small Anim Pract 2000; 15: 101-109
    CrossrefPubMedGoogle Scholar
  • 7 Beer KS, Silverstein DC. Controversies in the use of fresh frozen plasma in critically ill small animal patients. J Vet Emerg Crit Care 2015; 25: 101-106
    CrossrefPubMedGoogle Scholar
  • 8 Bergmann M, Friedl Y, Hartmann K. Passive Immunisierung bei Hund und Katze. Tierärztl Prax Ausg Kleintiere 2016; 44: 287-292
    PubMedGoogle Scholar
  • 9 Bersenas AM, Mathews KA, Allen DG. et al. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs. Am J Vet Res 2005; 66: 425-431
    CrossrefPubMedGoogle Scholar
  • 10 Blais M-C, Bianco D, Goggs R. et al. Consensus on the rational use of antithrombotics in veterinary critical care (CURATIVE): domain 3 – defining antithrombotic protocols. J Vet Emerg Crit Care 2019; 29: 60-74
    CrossrefPubMedGoogle Scholar
  • 11 Boscan P, Monnet E, Mama K. et al. Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs. Am J Vet Res 2011; 72: 1576-1579
    CrossrefPubMedGoogle Scholar
  • 12 Boyd CJ, Claus MA, Raisis AL. et al. Evaluation of biomarkers of kidney injury following 4 % succinylated gelatin and 6 % hydroxyethyl starch 130/0.4 administration in a canine hemorrhagic shock model. J Vet Emerg Crit Care (San Antonio) 2019; 29: 132-142
    CrossrefPubMedGoogle Scholar
  • 13 Bragg RF, Duffy AL, DeCecco FA. et al. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection. J Am Vet Med Assoc 2012; 240: 700-704
    CrossrefPubMedGoogle Scholar
  • 14 Brown AJ, Otto CM. Fluid therapy in vomiting and diarrhea. Vet Clin North Am Small Anim Pract 2008; 38: 653-675
    CrossrefPubMedGoogle Scholar
  • 15 Brunkhorst FM, Engel C, Bloos F. et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139
    CrossrefPubMedGoogle Scholar
  • 16 Brunner C, Swango L. Canine parvovirus infection: effects on the immune system and factors that predispose to severe disease. Comp Contin Educ Pract Vet 1985; 7: 979-989
    PubMedGoogle Scholar
  • 17 Burchell RK, Schoeman JP, Leisewitz AL. The central role of chloride in the metabolic acid-base changes in canine parvoviral enteritis. Vet J 2014; 200: 152-156
    CrossrefPubMedGoogle Scholar
  • 18 Butt AI, Khan BT, Khan A. et al. Ranitidine can potentiate the prokinetic effect of itopride at low doses – an in vitro study. J Ayub Med Coll Abbottabad 2017; 29: 554-558
    PubMedGoogle Scholar
  • 19 Cariou M, Lipscomb VJ, Brockman DJ. et al. Spontaneous gastroduodenal perforations in dogs: a retrospective study of 15 cases. Vet Rec 2009; 165: 436-441
    CrossrefPubMedGoogle Scholar
  • 20 Chan DL, Freeman LM, Labato MA. et al. Retrospective evaluation of partial parenteral nutrition in dogs and cats. J Vet Intern Med 2002; 16: 440-445
    CrossrefPubMedGoogle Scholar
  • 21 Chandler ML, Guilford WG, Payne-James J. Use of peripheral parenteral nutritional support in dogs and cats. J Am Vet Med Assoc 2000; 216: 669-673
    CrossrefPubMedGoogle Scholar
  • 22 Chiba T, Tokunaga Y, Ikeda K. et al. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies. Hepatogastroenterology 2007; 54: 1878-1881
    PubMedGoogle Scholar
  • 23 Cocciolillo S, Collins SM. The long-term functional consequences of acute infectious diarrhea. Curr Opin Gastroenterol 2016; 32: 1-6
    CrossrefPubMedGoogle Scholar
  • 24 Conner BJ. Treating hypoalbuminemia. Vet Clin North Am Small Anim Pract 2017; 47: 451-459
    CrossrefPubMedGoogle Scholar
  • 25 Couto CG. Disseminated intravascular coagulation in dogs and cats. Vet Med 1999; 94: 547-553
    PubMedGoogle Scholar
  • 26 Craft EM, Powell LL. The use of canine-specific albumin in dogs with septic peritonitis. J Vet Emerg Crit Care 2012; 22: 631-639
    CrossrefPubMedGoogle Scholar
  • 27 De la Puente-Redondo VA, Siedek EM, Benchaoui HA. et al. The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe. J Small Anim Pract 2007; 48: 93-98
    CrossrefPubMedGoogle Scholar
  • 28 De Mari K, Maynard L, Eun HM. et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial. Vet Rec 2003; 152: 105-108
    CrossrefPubMedGoogle Scholar
  • 29 De Morais HA, Bach JF, DiBartola SP. Metabolic acid-base disorders in the critical care unit. Vet Clin North Am Small Anim Pract 2008; 38: 559-574 x–xi
    CrossrefPubMedGoogle Scholar
  • 30 Decaro N, Buonavoglia C. Canine parvovirus– a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol 2012; 155: 1-12
    CrossrefPubMedGoogle Scholar
  • 31 Decaro N, Desario C, Billi M. et al. Evaluation of an in-clinic assay for the diagnosis of canine parvovirus. Vet J 2013; 198: 504-507
    CrossrefPubMedGoogle Scholar
  • 32 Deinert M. Enterale Sondenernährung von Kleintieren in der Praxis: Nasenschlundsonde und perkutane Magensonde. Tierärztl Prax 1997; 25: 627-636
    PubMedGoogle Scholar
  • 33 Devey JJ. Crystalloid and colloid fluid therapy. In: Ettinger SJ, Feldman EC. eds. Textbook of Veterinary Internal Medicine. Philadelphia: Elsevier Saunders; 2010: 487-496
    Google Scholar
  • 34 Dimmitt R. Clinical experience with cross-protective anti-endotoxin antiserum in dogs with parvoviral enteritis. Canine Pract 1991; 16: 23-26
    PubMedGoogle Scholar
  • 35 DiPalma J. Metoclopramide: a dopamine receptor antagonist. Am Fam Physician 1990; 41: 919-924
    PubMedGoogle Scholar
  • 36 Duffy A, Dow S, Ogilvie G. et al. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor. J Vet Pharmacol Ther 2010; 33: 352-356
    PubMedGoogle Scholar
  • 37 Dunn ME. Acquired coagulopathies. In: Ettinger SJ, Feldman EC. eds. Textbook of Veterinary Internal Medicine. Philadelphia: Elsevier Saunders; 2010: 797-801
    Google Scholar
  • 38 Egerbacher M, Edinger J, Tschulenk W. Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. Am J Vet Res 2001; 62: 704-708
    CrossrefPubMedGoogle Scholar
  • 39 Elson CO, Cong Y, McCracken VJ. et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005; 206: 260-276
    CrossrefPubMedGoogle Scholar
  • 40 European Medical Agency. Hydroxyethyl starch (HES) containing medicinal products. https://www.ema.europa.eu/en/medicines/human/referrals/hydroxyethyl-starch-hes-containing-medicinal-products Zugriff am 26.09.2019
    PubMedGoogle Scholar
  • 41 Fachinger V, Schlapp T, Strube W. et al. Poxvirus-induced immunostimulating effects on porcine leukocytes. J Virol 2000; 74: 7943-7951
    CrossrefPubMedGoogle Scholar
  • 42 Gajanayake I, Wylie CE, Chan DL. Clinical experience with a lipid-free, ready-made parenteral nutrition solution in dogs: 70 cases (2006–2012). J Vet Emerg Crit Care (San Antonio) 2013; 23: 305-313
    CrossrefPubMedGoogle Scholar
  • 43 Gamoh K, Senda M, Inoue Y. et al. Efficacy of an inactivated feline panleucopenia virus vaccine against a canine parvovirus isolated from a domestic cat. Vet Rec 2005; 157: 285-287
    CrossrefPubMedGoogle Scholar
  • 44 Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130: 1588-1594
    CrossrefPubMedGoogle Scholar
  • 45 Gerlach M, Proksch AL, Unterer S. et al. Efficacy of feline anti-parvovirus antibodies in the treatment of canine parvovirus infection. J Small Anim Pract 2017; 58 (07) 408-415
    CrossrefPubMedGoogle Scholar
  • 46 Ghauri SK, Javaeed A, Mustafa KJ. et al. Bicarbonate therapy for critically ill patients with metabolic acidosis: a systematic review. Cureus 2019; 11: e4297
    PubMedGoogle Scholar
  • 47 Glickman LT, Domanski LM, Patronek GJ. et al. Breed-related risk factors for canine parvovirus enteritis. J Am Vet Med Assoc 1985; 187: 589-594
    PubMedGoogle Scholar
  • 48 Glover PA, Rudloff E, Kirby R. Hydroxyethyl starch: a review of pharmacokinetics, pharmacodynamics, current products, and potential clinical risks, benefits, and use. J Vet Emerg Crit Care (San Antonio) 2014; 24: 642-661
    CrossrefPubMedGoogle Scholar
  • 49 Goddard A, Leisewitz AL, Christopher MM. et al. Prognostic usefulness of blood leukocyte changes in canine parvoviral enteritis. J Vet Intern Med 2008; 22: 309-316
    CrossrefPubMedGoogle Scholar
  • 50 Goddard A, Leisewitz AL. Canine parvovirus. Vet Clin North Am Small Anim Pract 2010; 40: 1041-1053
    CrossrefPubMedGoogle Scholar
  • 51 Goggs R, Blais MC, Brainard BM. et al. American college of veterinary emergency and critical care (ACVECC) consensus on the rational use of antithrombotics in veterinay critical care (CURATIVE) guidelines: small animal. J Vet Emerg Crit Care (San Antonio) 2019; 29: 12-36
    CrossrefPubMedGoogle Scholar
  • 52 Greene CE, Decaro N. Canine viral enteritis. In: Greene CE. ed. Infectious Diseases of the Dog and Cat. Philadelphia: Elsevier Saunders; 2013: 67-75
    Google Scholar
  • 53 Greene CE, Levy JK. Immunoprophylaxis. In: Greene CE. ed. Infectious Diseases of the Dog and Cat. Philadelphia: Elsevier Saunders; 2013: 1163-1205
    Google Scholar
  • 54 Grover M. Role of gut pathogens in development of irritable bowel syndrome. Indian J Med Res 2014; 139: 11-18
    PubMedGoogle Scholar
  • 55 Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000; 355: 827-835
    CrossrefPubMedGoogle Scholar
  • 56 Hadfield RJ, Sinclair DG, Houldsworth PE. et al. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 1995; 152: 1545-1548
    CrossrefPubMedGoogle Scholar
  • 57 Hall JA, Washabau RJ. Gastronintestinal prokinetic therapy: dopaminergic antagonist drugs. Comp Contin Educ Pract Vet 1997; 19: 214-220
    PubMedGoogle Scholar
  • 58 Hartmann K, Hein J. Feline Panleukopenie. In: Hartmann K, Hein J. Hrsg. Infektionskrankheiten der Katze. Hannover: Schlütersche; 2008: 87-98
    Google Scholar
  • 59 Heel KA, Kong SE, McCauley RD. et al. The effect of minimum luminal nutrition on mucosal cellularity and immunity of the gut. J Gastroenterol Hepatol 1998; 13: 1015-1019
    CrossrefPubMedGoogle Scholar
  • 60 Hinz B, Cheremina O, Bachmakov J. et al. Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. FASEB J 2007; 21: 2343-2351
    CrossrefPubMedGoogle Scholar
  • 61 Hoffmann R. Disseminierte intravasale Gerinnung (Verbrauchskoagulopathie) beim Haustier. Tierärztl Prax 1974; 2: 375-381
    PubMedGoogle Scholar
  • 62 Hohdatsu T, Pu R, Torres BA. et al. Passive antibody protection of cats against feline immunodeficiency virus infection. J Virol 1993; 67: 2344-2348
    CrossrefPubMedGoogle Scholar
  • 63 Hopper K. Is bicarbonate therapy useful?. Vet Clin North Am Small Anim Pract 2017; 47: 343-349
    CrossrefPubMedGoogle Scholar
  • 64 Hutchinson KM, Shaw SP. A review of central venous pressure and its reliability as a hemodynamic monitoring tool in veterinary medicine. Top Companion Anim Med 2016; 31: 109-121
    CrossrefPubMedGoogle Scholar
  • 65 Idowu O, Heading K. Hypoglycemia in dogs: causes, management, and diagnosis. Can Vet J 2018; 59: 642-649
    PubMedGoogle Scholar
  • 66 Ishibashi K, Maede Y, Ohsugi T. et al. Serotherapy for dogs infected with canine parvovirus. Jap J Vet Sci 1983; 45: 59-66
    CrossrefPubMedGoogle Scholar
  • 67 Ishiwata K, Minagawa T, Kajimoto T. Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs. J Vet Med Sci 1998; 60: 911-917
    CrossrefPubMedGoogle Scholar
  • 68 Kaiser L, Wat C, Mills T. et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163: 1667-1672
    CrossrefPubMedGoogle Scholar
  • 69 Kariuki Njenga M, Nyaga P, Buoro I. et al. Effectiveness of fluids and antibiotics as supportive therapy of canine parvovirus-2 enteritis in puppies. Bull Anim Hlth Prod Afr 1990; 38: 379-389
    PubMedGoogle Scholar
  • 70 Kilian E, Suchodolski JS, Hartmann K. et al. Long-term effects of canine parvovirus infection in dogs. PLoS One 2018; 13: e0192198
    CrossrefPubMedGoogle Scholar
  • 71 Konijnenbelt-Peters J, van der Heijden C, Ekhart C. et al. Metamizole (dipyrone) as an alternative agent in postoperative analgesia in patients with contraindications for nonsteroidal anti-inflammatory drugs. Pain Pract 2017; 17: 402-408
    CrossrefPubMedGoogle Scholar
  • 72 Kraft W, Kuffer M. [Treatment of severe neutropenias in dogs and cats with filgrastim]. Tierärztl Prax 1995; 23: 609-613
    PubMedGoogle Scholar
  • 73 Krakowka S, Olsen RG, Axthelm MK. et al. Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine. J Am Vet Med Assoc 1982; 180: 137-139
    PubMedGoogle Scholar
  • 74 Kuwabara M, Nariai Y, Horiuchi Y. et al. Immunological effects of recombinant feline interferon-ω (KT-80) administration in the dog. Microbiol Immunol 2006; 50: 637-641
    CrossrefPubMedGoogle Scholar
  • 75 Lamm CG, Rezabek GB. Parvovirus infection in domestic companion animals. Vet Clin North Am Small Anim Pract 2008; 38: 837-850
    CrossrefPubMedGoogle Scholar
  • 76 Lascelles BD, Blikslager AT, Fox SM. et al. Gastrointestinal tract perforation in dogs treated with a selective cyclooxygenase-2 inhibitor: 29 cases (2002–2003). J Am Vet Med Assoc 2005; 227: 1112-1117
    CrossrefPubMedGoogle Scholar
  • 77 Lee JA, Cohn LA. Fluid therapy for pediatric patients. Vet Clin North Am Small Anim Pract 2017; 47: 373-382
    CrossrefPubMedGoogle Scholar
  • 78 Levy JK, Crawford PC, Collante WR. et al. Use of adult cat serum to correct failure of passive transfer in kittens. J Am Vet Med Assoc 2001; 219: 1401-1405
    CrossrefPubMedGoogle Scholar
  • 79 Lippert AC, Fulton Jr. RB, Parr AM. A retrospective study of the use of total parenteral nutrition in dogs and cats. J Vet Intern Med 1993; 7: 52-64
    CrossrefPubMedGoogle Scholar
  • 80 London C. Hematopoietic cytokines: the myelopoietic factors. In: Bonagura J. ed. Kirk‘s Current Veterinary Therapy XIII Small Animal Practice. Philadelphia: Saunder; 2000: 403-408
    Google Scholar
  • 81 Lopez-Novoa JM, Quiros Y, Vicente L. et al. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 2011; 79: 33-45
    CrossrefPubMedGoogle Scholar
  • 82 Lorenzutti AM, Martin-Flores M, Litterio NJ. et al. A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs. Can Vet J 2017; 58: 35-38
    PubMedGoogle Scholar
  • 83 Lynch AM, deLaforcade AM, Sharp CR. Clinical experience of anti-Xa monitoring in critically ill dogs receiving dalteparin. J Vet Emerg Crit Care (San Antonio) 2014; 24: 421-428
    CrossrefPubMedGoogle Scholar
  • 84 Macintire D, Smith-Carr S. Canine parvovirus. Part II. Clinical signs, diagnosis, and treatment. Comp Cont Educ Pract Vet 1997; 19: 291-302
    PubMedGoogle Scholar
  • 85 Macintire D, Smith-Carr S, Jones R. et al. Treatment of dogs naturally infected with canine parvovirus with lyophilized canine IgG. Proceedings 17th Annual Conference of the American College of Veterinary Internal Medicine 1999, Chicago.
    PubMedGoogle Scholar
  • 86 Macintire DK. Pediatric fluid therapy. Vet Clin North Am Small Anim Pract 2008; 38: 621-627 xii
    CrossrefPubMedGoogle Scholar
  • 87 Mann FA, Boon GD, Wagner-Mann CC. et al. Ionized and total magnesium concentrations in blood from dogs with naturally acquired parvoviral enteritis. J Am Vet Med Assoc 1998; 212: 1398-1401
    PubMedGoogle Scholar
  • 88 Mantione NL, Otto CM. Characterization of the use of antiemetic agents in dogs with parvoviral enteritis treated at a veterinary teaching hospital: 77 cases (1997–2000). J Am Vet Med Assoc 2005; 227: 1787-1793
    CrossrefPubMedGoogle Scholar
  • 89 Marks SL, Kook PH, Papich MG. et al. ACVIM consensus statement: support for rational administration of gastrointestinal protectants to dogs and cats. J Vet Intern Med 2018; 32: 1823-1840
    CrossrefPubMedGoogle Scholar
  • 90 Martin G, Baverel G. Lactate, alanine and glutamine metabolism in isolated canine pup liver cells. Biochim Biophys Acta (BBA)-General Subjects 1983; 760: 230-237
    CrossrefPubMedGoogle Scholar
  • 91 Martin V, Najbar W, Gueguen S. et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet Microbiol 2002; 89: 115-127
    CrossrefPubMedGoogle Scholar
  • 92 Martyn JC, Davidson BE, Studdert MJ. Nucleotide sequence of feline panleukopenia virus: comparison with canine parvovirus identifies host-specific differences. J Gen Virol 1990; 71 (Pt 11) 2747-2753
    CrossrefPubMedGoogle Scholar
  • 93 Mathews KA, Barry M. The use of 25 % human serum albumin: outcome and efficacy in raising serum albumin and systemic blood pressure in critically ill dogs and cats. J Vet Emerg Crit Care 2005; 15: 110-118
    CrossrefPubMedGoogle Scholar
  • 94 Mathews KA. The therapeutic use of 25 % human serum albumin in critically ill dogs and cats. Vet Clin North Am Small Anim Pract 2008; 38: 595-605
    CrossrefPubMedGoogle Scholar
  • 95 Mayr A, Mayr B. A new concept in prophylaxis and therapy: paramunization by poxvirus inducers. Pesqui Vet Bras 1999; 19: 91-98
    CrossrefPubMedGoogle Scholar
  • 96 Mazzaferro EM, Rudloff E, Kirby R. The role of albumin replacement in the critically ill veterinary patient. J Vet Emerg Crit Care 2002; 12: 113-124
    CrossrefPubMedGoogle Scholar
  • 97 McCullers JA. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J Infect Dis 2004; 190: 519-526
    CrossrefPubMedGoogle Scholar
  • 98 McMichael M. Pediatric emergencies. Vet Clin North Am Small Anim Pract 2005; 35: 421-434
    CrossrefPubMedGoogle Scholar
  • 99 McMichael M. Critically ill neonatal and pediatric patients. In: Silverstein D, Hopper K. eds. Small Animal Critical Care Medicine. Philadelphia: Elsevier Saunders; 2014: 820-825
    Google Scholar
  • 100 Mellett AM, Nakamura RK, Bianco D. A prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia. J Vet Intern Med 2011; 25: 71-75
    CrossrefPubMedGoogle Scholar
  • 101 Mensack S. Fluid therapy: options and rational administration. Vet Clin North Am Small Anim Pract 2008; 38: 575-586 xi
    CrossrefPubMedGoogle Scholar
  • 102 Meunier PC, Cooper BJ, Appel MJ. et al. Pathogenesis of canine parvovirus enteritis: sequential virus distribution and passive immunization studies. Vet Pathol 1985; 22: 617-624
    CrossrefPubMedGoogle Scholar
  • 103 Meunier PC, Cooper BJ, Appel MJ. et al. Pathogenesis of canine parvovirus enteritis: the importance of viremia. Vet Pathol 1985; 22: 60-71
    CrossrefPubMedGoogle Scholar
  • 104 Minagawa T, Ishiwata K, Kajimoto T. Feline interferon-omega treatment on canine parvovirus infection. Vet Microbiol 1999; 69: 51-53
    CrossrefPubMedGoogle Scholar
  • 105 Mischke R, Barth T, Wohlsein P. et al. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis. Res Vet Sci 2001; 70: 221-225
    CrossrefPubMedGoogle Scholar
  • 106 Mitchell SA, Zwijnenberg RJ, Huang J. et al. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia. Aust Vet J 2012; 90: 468-473
    CrossrefPubMedGoogle Scholar
  • 107 Mochizuki M, Nakatani H, Yoshida M. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet Microbiol 1994; 39: 145-152
    CrossrefPubMedGoogle Scholar
  • 108 Mohr AJ, Leisewitz AL, Jacobson LS. et al. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis. J Vet Intern Med 2003; 17: 791-798
    CrossrefPubMedGoogle Scholar
  • 109 Moore FA, Feliciano DV, Andrassy RJ. et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 1992; 216: 172-183
    CrossrefPubMedGoogle Scholar
  • 110 Moore LE. Fluid therapy in the hypoproteinemic patient. Vet Clin North Am Small Anim Pract 1998; 28: 709-715
    CrossrefPubMedGoogle Scholar
  • 111 Ohno T, Mochiki E, Ando H. et al. Glutamine decreases the duration of postoperative ileus after abdominal surgery: an experimental study of conscious dogs. Dig Dis Sci 2009; 54: 1208-1213
    CrossrefPubMedGoogle Scholar
  • 112 Otto CM, Drobatz KJ, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997; 11: 65-70
    CrossrefPubMedGoogle Scholar
  • 113 Otto CM, Rieser TM, Brooks MB. et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217: 1500-1504
    CrossrefPubMedGoogle Scholar
  • 114 Otto CM, Jackson CB, Rogell EJ. et al. Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial. J Vet Intern Med 2001; 15: 355-360
    CrossrefPubMedGoogle Scholar
  • 115 Pachtinger GE, Drobatz K. Assessment and treatment of hypovolemic states. Vet Clin North Am Small Anim Pract 2008; 38: 629-643 xii
    CrossrefPubMedGoogle Scholar
  • 116 Paquette F, Bernier-Jean A, Brunette V. et al. Acute kidney injury and renal recovery with the use of aminoglycosides: a large retrospective study. Nephron 2015; 131: 153-160
    CrossrefPubMedGoogle Scholar
  • 117 Parrish CR. Host range relationships and the evolution of canine parvovirus. Vet Microbiol 1999; 69: 29-40
    CrossrefPubMedGoogle Scholar
  • 118 Pereira GQ, Gomes LA, Santos IS. et al. Fecal microbiota transplantation in puppies with canine parvovirus infection. J Vet Intern Med 2018; 32: 707-711
    CrossrefPubMedGoogle Scholar
  • 119 Perner A, Haase N, Guttormsen AB. et al. Hydroxyethyl starch 130/0.42 versus Ringer‘s acetate in severe sepsis. N Engl J Med 2012; 367: 124-134
    CrossrefPubMedGoogle Scholar
  • 120 Pollock RV, Carmichael LE. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J Am Vet Med Assoc 1982; 180: 37-42
    PubMedGoogle Scholar
  • 121 Prittie J. Canine parvoviral enteritis: a review of diagnosis, management, and prevention. J Vet Emerg Crit Care 2004; 14: 167-176
    CrossrefPubMedGoogle Scholar
  • 122 Proksch AL, Unterer S, Truyen U. et al. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection. Vet J 2014; 202: 340-347
    CrossrefPubMedGoogle Scholar
  • 123 Proksch AL, Hartmann K. [Diagnostic tools for canine parvovirus infection]. Tierärztl Prax Ausg Kleintiere 2015; 43: 351-357
    PubMedGoogle Scholar
  • 124 Ramsey DS, Kincaid K, Watkins JA. et al. Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs. J Vet Pharmacol Ther 2008; 31: 538-543
    CrossrefPubMedGoogle Scholar
  • 125 Reuter JD, Marks SL, Rogers QR. et al. Use of total parenteral nutrition in dogs: 209 cases (1988–1995). J Vet Emerg Crit Care 1998; 8: 201-213
    CrossrefPubMedGoogle Scholar
  • 126 Reviewers CIGA. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998; 317: 235-240
    CrossrefPubMedGoogle Scholar
  • 127 Rewerts JM, McCaw DL, Cohn LA. et al. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection. J Am Vet Med Assoc 1998; 213: 991-992
    PubMedGoogle Scholar
  • 128 Ruehl W, Mills C, Feldman BF. Rational therapy in disseminated intravascular coagulation. J Am Vet Med Assoc 1982; 181: 76-78
    PubMedGoogle Scholar
  • 129 Salter BS, Weiner MM, Trinh MA. et al. Heparin-induced thrombocytopenia: a comprehensive clinical review. J Am Coll Cardiol 2016; 67: 2519-2532
    CrossrefPubMedGoogle Scholar
  • 130 Savigny MR, Macintire DK. Use of oseltamivir in the treatment of canine parvoviral enteritis. J Vet Emerg Crit Care (San Antonio) 2010; 20: 132-142
    CrossrefPubMedGoogle Scholar
  • 131 Schultz RD, Thiel B, Mukhtar E. et al. Age and long-term protective immunity in dogs and cats. J Comp Pathol 2010; 142 (Suppl. 01) S102-108
    CrossrefPubMedGoogle Scholar
  • 132 Sedlacek HS, Ramsey DS, Boucher JF. et al. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs. J Vet Pharmacol Ther 2008; 31: 533-537
    CrossrefPubMedGoogle Scholar
  • 133 Serpa Neto A, Veelo DP, Peireira VG. et al. Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature. J Crit Care 2014; 29: 185.e181-187
    PubMedGoogle Scholar
  • 134 Silverstein D, Santoro-Beer K. Daily intravenous fluid therapy. In: Silverstein D, Hopper K. eds. Small Animal Critical Care Medicine. Philadelphia: Elsevier Saunders; 2014: 316-321
    Google Scholar
  • 135 Smiley LE, Garvey MS. The use of hetastarch as adjunct therapy in 26 dogs with hypoalbuminemia: a phase two clinical trial. J Vet Intern Med 1994; 8: 195-202
    CrossrefPubMedGoogle Scholar
  • 136 Smith-Carr S, Macintire D, Swango L. Canine parvovirus: Part I. Pathogenesis and vaccination. Comp Cont Educ Pract Vet 1997; 19: 125-133
    PubMedGoogle Scholar
  • 137 Smith SA. Antithrombotic therapy. Top Companion Anim Med 2012; 27: 88-94
    CrossrefPubMedGoogle Scholar
  • 138 Streck AF, Ruster D, Truyen U. et al. An updated TaqMan real-time PCR for canine and feline parvoviruses. J Virol Methods 2013; 193: 6-8
    CrossrefPubMedGoogle Scholar
  • 139 Sullivan LA, Lenberg JP, Boscan P. et al. Assessing the efficacy of maropitant versus ondansetron in the treatment of dogs with parvoviral enteritis. J Am Anim Hosp Assoc 2018; 54: 338-343
    CrossrefPubMedGoogle Scholar
  • 140 Sutalo S, Ruetten M, Hartnack S. et al. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats. J Vet Intern Med 2015; 29: 840-846
    CrossrefPubMedGoogle Scholar
  • 141 Tatsuo MA, Carvalho WM, Silva CV. et al. Analgesic and antiinflammatory effects of dipyrone in rat adjuvant arthritis model. Inflammation 1994; 18: 399-405
    CrossrefPubMedGoogle Scholar
  • 142 Tello L, Perez-Freytes R. Fluid and electrolyte therapy during vomiting and diarrhea. Vet Clin North Am Small Anim Pract 2017; 47: 505-519
    CrossrefPubMedGoogle Scholar
  • 143 Tenne R, Sullivan LA, Contreras ET. et al. Palatability and clinical effects of an oral recuperation fluid during the recovery of dogs with suspected parvoviral enteritis. Top Companion Anim Med 2016; 31: 68-72
    CrossrefPubMedGoogle Scholar
  • 144 Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol 2009; 15: 3591-3596
    CrossrefPubMedGoogle Scholar
  • 145 Tolbert K, Bissett S, King A. et al. Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs. J Vet Intern Med 2011; 25: 47-54
    CrossrefPubMedGoogle Scholar
  • 146 Tonini M, Cipollina L, Poluzzi E. et al. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 2004; 19: 379-390
    CrossrefPubMedGoogle Scholar
  • 147 Truyen U, Blewaska S, Schultheiss U. Untersuchung der antiviralen Wirksamkeit von Interferon-Omega gegenausgewählte Viren von Hund und Katze. Prakt Tierarzt 2002; 83: 862-865
    PubMedGoogle Scholar
  • 148 Truyen U. Evolution of canine parvovirus – a need for new vaccines?. Vet Microbiol 2006; 117: 9-13
    CrossrefPubMedGoogle Scholar
  • 149 Turk J, Miller M, Brown T. et al. Coliform septicemia and pulmonary disease associated with canine parvoviral enteritis: 88 cases (1987–1988). J Am Vet Med Assoc 1990; 196: 771-773
    PubMedGoogle Scholar
  • 150 Van Nguyen S, Umeda K, Yokoyama H. et al. Passive protection of dogs against clinical disease due to canine parvovirus-2 by specific antibody from chicken egg yolk. Can J Vet Res 2006; 70: 62-64
    PubMedGoogle Scholar
  • 151 Venturini CM, Isakson P, Needleman P. Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms. Curr Opin Nephrol Hypertens 1998; 7: 79-82
    CrossrefPubMedGoogle Scholar
  • 152 Wada H, Thachil J, Di Nisio M. et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost 2013; 11: 761-767
    CrossrefPubMedGoogle Scholar
  • 153 Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Semin Thromb Hemost 2015; 41: 49-60
    Article in Thieme ConnectPubMedGoogle Scholar
  • 154 Wessels B, Gaffin S. Anti-endotoxin immunotherapy for canine parvovirus endotoxaemia. J Small Anim Pract 1986; 27: 609-615
    CrossrefPubMedGoogle Scholar
  • 155 Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135: 149-164
    PubMedGoogle Scholar
  • 156 Willard MD. Digestive system disorders – general therapeutic principles. In: Nelson RW, Couto CG. eds. Small Animal Internal Medicine. Philadelphia: Elsevier; 2014: 410-427
    Google Scholar
  • 157 Wilson S, Illambas J, Siedek E. et al. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c. Vaccine 2014; 32: 5420-5424
    CrossrefPubMedGoogle Scholar
  • 158 Wong C, Koenig A. The colloid controversy: are colloids bad and what are the options?. Vet Clin North Am Small Anim Pract 2017; 47: 411-421
    CrossrefPubMedGoogle Scholar
  • 159 Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil 2004; 16 (Suppl. 02) 17-28
    CrossrefPubMedGoogle Scholar
  • 160 Yalcin E, Keser GO. Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs. J Vet Pharmacol Ther 2017; 40: 599-603
    CrossrefPubMedGoogle Scholar
  • 161 Yoshida K, Yabe K, Nishida S. et al. Pharmacokinetic disposition and arthropathic potential of oral ofloxacin in dogs. J Vet Pharmacol Ther 1998; 21: 128-132
    CrossrefPubMedGoogle Scholar